Cervical artery dissection expands the cardiovascular phenotype in FBN1-related Weill-Marchesani syndrome

Am J Med Genet A. 2017 Sep;173(9):2551-2556. doi: 10.1002/ajmg.a.38353. Epub 2017 Jul 11.

Abstract

Weill-Marchesani syndrome (WMS) is a rare form of acromelic dysplasia that is characterized by distinctive skeletal, ocular, and cardiovascular abnormalities. Previously described cardiac manifestations of WMS include aortic and pulmonary valve stenosis, mitral valve prolapse, mitral stenosis, and QTc prolongation. Autosomal dominant forms of WMS result from heterozygous pathogenic variants in FBN1, a gene with a well characterized role in the pathogenesis of thoracic aortic aneurysm (TAA) in the context of Marfan syndrome. In contrast, only one patient has been reported with aortic disease in WMS. Although the risk of aortic dissection from preceding TAA remains the leading cause of morbidity for individuals with Marfan syndrome, rare reports of arterial dissection in the peripheral vasculature have been described. Peripheral artery dissection has not been previously reported in other FBN1-related diseases. We describe a three generation family with FBN1-related WMS whose cardiovascular manifestations include TAA and cervical artery dissection, thus expanding the cardiovascular phenotype of WMS. Further research is required to quantify these risks and establish appropriate recommendations for cardiovascular imaging, medical management, and prophylactic surgical intervention in individuals with FBN1--related acromelic dysplasia.

Keywords: Weill-Marchesani syndrome; acromelic dysplasia; cervical artery dissection; thoracic aortic aneurysm.

MeSH terms

  • Adult
  • Aortic Aneurysm, Thoracic / genetics*
  • Aortic Aneurysm, Thoracic / physiopathology
  • Aortic Dissection / genetics
  • Aortic Dissection / physiopathology
  • Cardiovascular Abnormalities / genetics*
  • Cardiovascular Abnormalities / physiopathology
  • Child
  • Child, Preschool
  • Female
  • Fibrillin-1 / genetics*
  • Heterozygote
  • Humans
  • Male
  • Marfan Syndrome / genetics
  • Marfan Syndrome / physiopathology
  • Mutation
  • Pedigree
  • Phenotype
  • Weill-Marchesani Syndrome / genetics*
  • Weill-Marchesani Syndrome / physiopathology

Substances

  • FBN1 protein, human
  • Fibrillin-1